68Ga-DOTA-Sar10-Nectin-4

N/A

Report date: 2026/05/20 20:02:01

NME

Base Information

Drug Name68Ga-DOTA-Sar10-Nectin-4

Drug Alias Name68Ga-FZ-NR-168Ga-DOTA-Sar10-Nectin-4[68Ga]DOTA-Sar-10-Nectin-4[68Ga]DOTA-Sar10-FDSH[68Ga]FZ-NR-1 +[6]

ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)Small molecules > Synthetic peptideRadiation-emitting products > Radionuclide Drug Conjugates +[5]

Mechanisms of ActionNectin-4 binders

TargetsNectin-4

Therapy Area/IndicationsTriple Negative Breast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaClinical

Originator CompaniesFudan University Shanghai Cancer Center

China Registration ClassN/A

Develop Information

Active CompaniesFudan University Shanghai Cancer Center

Inactive CompaniesN/A

Active IndicationsTriple Negative Breast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A